While this study was underway, two other laboratories found that knockout of DDI2 reduced recovery of proteasome activity in multiple myeloma and NIH-3T3 cells pulse-treated with PIs by ~30% (Chen et al., 2022; Northrop et al., 2020). This evidence concerns the gene DDI2 and AL amyloidosis.